Rossari Biotech Balance Sheet
- Market cap
- ₹2,268 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹294.80 – ₹552.76
As of FY25, Rossari Biotech had total assets of ₹1,474 crore and borrowings of ₹272 crore, against shareholders' equity of ₹1,140 crore — a debt-to-equity ratio of 0.35.
Rossari Biotech balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 1,020 |
| Borrowings | 272 |
| Other liabilities | 181 |
| Total liabilities | 1,474 |
| Fixed assets | 794 |
| Capital work in progress | 45 |
| Investments | 340 |
| Other assets | 340 |
| Total assets | 1,474 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹143.67
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Rossari Biotech balance sheet — frequently asked questions
What is the total debt of Rossari Biotech?
Rossari Biotech reported borrowings of ₹272 crore as of FY25.
What is Rossari Biotech's debt-to-equity ratio?
Based on the FY25 balance sheet, Rossari Biotech's debt-to-equity ratio is 0.35 — borrowings of ₹272 crore against equity capital and reserves of ₹1,140 crore.
What are Rossari Biotech's total assets?
Rossari Biotech's total assets were ₹1,474 crore as of FY25, including fixed assets of ₹794 crore and investments of ₹340 crore.
What is the book value per share of Rossari Biotech?
The book value per share of Rossari Biotech is ₹143.67, based on the latest reported balance sheet.
Same Data For Peers
Trade Rossari Biotech With ATS
Track ROSSARI live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.